Screening of malignant pleural effusion by discriminant analysis

International Journal of Tuberculosis and Lung Disease

Volumn 7, Issue 9, 2003, Pages 892-898

  Carrión Valero, Francisco ^a   Perpina Tordera M ^b   Sanchis Aldas J ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Diagnosis; Discriminant analysis; Malignant; Pleural effusion; Tuberculosis

Indexed keywords

GLUCOSE; IRON;

ADULT; ARTICLE; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; DISEASE CLASSIFICATION; EFFUSION; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MALIGNANT PLEURAL EFFUSION; MEDICAL RECORD; MONOCYTE; PLEURA EFFUSION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEDIMENTATION RATE; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

ADULT; AGE FACTORS; AGED; BLOOD SEDIMENTATION; DIAGNOSIS, DIFFERENTIAL; DISCRIMINANT ANALYSIS; FEMALE; HUMANS; MALE; MASS SCREENING; MEDICAL RECORDS; MIDDLE AGED; PLEURAL EFFUSION; PLEURAL EFFUSION, MALIGNANT; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 0141522955     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Morgan R L, De Young B R, McGaughy V R, Niemann T H. MOC-31 aids in the differentiation between adenocarcinoma and reactive mesothelial cells. Cancer 1999; 87: 390-394.
2. Light R W. Pleural diseases. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001.
3. Kuralay F, Tokgoz Z, Comlekci A. Diagnostic usefulness of tumour marker levels in pleural effusions of malignant and benign origin. Clin Chim Acta 2000; 300: 43-55.
4. Marel M, Zrustová M, Stasny B, Light R W. The incidence of pleural effusion in a well-defined region: epidemiologic study in central Bohemia. Chest 1993; 104: 1486-1489.
5. Valdés L, Alvarez D, Valle J M, Pose A, San José E. The etiology of pleural effusions in an area with high incidence of tuberculosis. Chest 1996; 109: 158-162.
6. Diacon A H, Wyser C, Bolliger C T, et al. Prospective randomized comparison of thoracoscopic talc poudrage under local anesthesia versus bleomycin instillation for pleurodesis in malignant pleural effusions. Am J Respir Crit Care Med 2000; 162: 1445-1449.
7. Villena V, López Encuentra A, Echave-Sustaera J, Álvarez Martínez C, Martín Escribano P. Estudio prospectivo de 1.000 pacientes consecutivos con derrame pleural. Etiología del derrame y características de los pacientes. Arch Bronconeumol 2002; 38: 21-26.
8. Antony V B, Loddenkemper R, Astoul P H, et al. Management of malignant pleural effusions. Am J Respir Crit Care Med 2000; 162: 1987-2001.
9. Hsu C. Cytologic detection of malignancy in pleural effusion: a review of 5,255 samples from 3,811 patients. Drug Cytopathol 1987; 3: 8-12.
10. Loddenkemper R, Grosser H, Gabler A, Mai J, Preussler H, Brant H J. Prospective evaluation of biopsy methods in the diagnosis of malignant pleural effusions: intrapatient comparison between pleural fluid cytology, blind needle biopsy and thoracoscopy. Am Rev Respir Dis 1983; 127 (Suppl 4): 114.
11. Rijken A, Dekker A, Taylor S, Hoffman P, Blank M, Krause J. Diagnostic value of DNA analysis in effusions by flow cytometry and image analysis. Am J Clin Pathol 1991; 95: 6-12.
12. Sahn S A. Pleural diagnostic techniques. Curr Opin Pulm Med 1995; 1: 324-330.
13. Fenton K N, Richardson J D. Diagnosis and management of malignant pleural effusions. Am J Surg 1995; 170: 69-74.
14. Poe R H, Israel R H, Utell M J, Hall W J, Greenblatt D W, Kallay M C. Sensitivity, specificity, and predictive values of closed pleural biopsy. Arch Intern Med 1984; 144: 325-328.
15. Escudero Bueno C, García Clemente M, Cuesta Castro B, et al. Cytological and bacteriologic analysis of fluid and pleural biopsy specimens with Cope's needle. Study of 414 patients. Arch Intern Med 1990; 150: 1190-1194.
16. Prakash U B S, Reiman H M. Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusions: analysis of 414 cases. Mayo Clin Proc 1985; 60: 158-164.
17. Jay S J. Diagnostic procedures for pleural disease. Clin Chest Med 1985; 6: 33-48.
18. Starr R L, Sherman M E. The value of multiple preparations in the diagnosis of malignant pleural effusions. A cost-benefit analysis. Acta Cytol 1991; 35: 533-537.
19. Salyer W R, Eggleston J C, Erozan Y S. Efficay of pleural needle biopsy and pleural fluid cytopathology in the diagnosis of malignant neoplasm involving the pleura. Chest 1975; 67: 536-539.
20. Loddenkemper R. Thoracoscopy. State of the art. Eur Respir J 1998; 11: 213-221.
21. Colt H G. Thoracoscopy. A prospective study of safety and outcome. Chest 1995; 108: 324-329.
22. Benko I, Molnar T F, Horvath D P. Palliative treatment of malignant pleural effusions by videoassisted thoracoscopic surgery. Acta Chir Hung 1999; 38: 131-133.
23. De Groot M, Walther G. Thoracoscopy in undiagnosed pleural effusions. S Afr Med J 1998; 88: 706-711.
24. Pettersson T, Klockars M, Fröseth B. Neuron-specific enolase in the diagnosis of small-cell lung cancer with pleural effusion: a negative report. Eur Respir J 1988; 1: 698-700.
25. Riantawan P, Sangsayan P, Bangpattanasiri K, Rojanaraweewong P. Limited additive value of pleural fluid carcinoembryonic antigen level in malignant pleural effusion. Respiration 2000; 67: 24-29.
26. Nagel H, Schlott T, Schulz G M, Droese M. Gene expression analysis of the catalytic subunit of human telomerase (hEST 2) in the differential diagnosis of serous effusions. Diagn Mol Pathol 2001; 10: 60-65.
27. Miédougé M, Rouzaud P, Salama G, et al. Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions. Br J Cancer 1999; 81: 1059-1065.
28. Carrión-Valero F, Perpiñá-Tordera M. Screening of tuberculous pleural effusion by discriminant analysis. Int J Tuberc Lung Dis 2001; 5: 673-679.
29. Light R W, MacGregor M I, Luchsinger P C, Ball W C. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972; 77: 507-513.
30. Kleinbaum D G, Kupper L L, Muller K E. Applied regresion analysis and other multivariate methods. 2nd ed. Boston: PWS-KENT Publishing Co., 1988.
31. Järvi O H, Kunnas R J, Laitio M T, Tyrkkö J E S. The accuracy and significance of cytologic cancer diagnosis of pleural effusions. A followup study of 338 patients. Acta Cytol 1972; 16: 152-158.
32. Sahn S A. Malignant pleural effusions. In: Fishman A P, ed. Fishman's. Pulmonary diseases and disorders. Vol 1. 3rd ed. New York: McGraw-Hill, 1998:1429-1438.
33. Tomlinson J R, Sahn S A. Invasive procedures in the diagnosis of pleural disease. Semin Respir Med 1987; 9: 30-36.
34. Solberg H E. Discriminant analysis in clinical chemistry. Scand J Clin Lab Invest 1975; 35: 705-712.
35. Griner P F, Mayewski R J, Mushlin A I, Greenland P H. Selection and interpretation of diagnostic tests and procedures. Principles and applications. Ann Intern Med 1981; 94: 553-600.
36. Moores D W O. Malignant pleural effusion. Semin Oncol 1991; 18 (Suppl 2): 59-61.
37. Berger H W, Maher G. Decreased glucose concentration in malignant pleural effusions. Am Rev Respir Dis 1971; 103: 427-429.
38. Light R W, Ball W C. Glucose and amylase in pleural effusions. JAMA 1973; 225: 257-260.
39. Rodríguez-Panadero F, López-Mejías J. Low glucose and pH levels in malignant pleural effusion. Am Rev Respir Dis 1989; 139: 663-667.
40. Light R W, Girard W M, Jenkinson S G, George R B. Parapneumonic effusions. Am J Med 1980; 69: 507-511.
41. Rodríguez-Panadero F, López-Mejías J. Survival time of patients with pleural metastatic carcinomas predicted by glucose and pH studies. Chest 1989; 95: 320-324.
42. Schulze M, Boehle A S, Kurdow R, Dohrmann P, Henne Bruns D. Effective treatment of malignant pleural effusion by minimal invasive thoracic surgery: thoracoscopic talc pleurodesis and pleuroperitoneal shunts in 101 patients. Ann Thorac Surg 2001; 71: 1809-1812.
43. Villena V, López-Encuentra A, Echave-Sustaeta J, Martín-Escribano P, Ortuño-de-Soto B, Estenoz-Alfaro J. Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients. Cancer 1996; 78: 736-740.
44. Hazard J T, Drysdale J W. Ferritinaemia in cancer. Nature 1977; 265: 755-756.
45. Shuster J, Gold P, Poulik M D. Beta2-microglobulin levels in cancerous and other disease states. Clin Chim Acta 1976; 67: 307-313.
46. Braunschweing R, Yan P, Guilleret I, et al. Detection of malignant effusions: comparison of a telomerase assay and cytologic examination. Diagn Cytopathol 2001; 24: 174-180.
47. Harris R J, Kavuru M S, Rice T W, Kirby T J. The diagnostic and therapeutic utility of thoracoscopy. A review. Chest 1995; 108: 828-841.
48. Boutin C, Astoul Ph, Seitz B. The role of thoracoscopy in the evaluation and management of pleural effusions. Lung 1990; 168 (Suppl): 1113-1121.